Search Results 591-600 of 18476 for Prednisone

1. EF-41/KEYNOTE D58: Phase 3 Study Of Optune Concomitant With Temozolomide Plus Pembrolizumab In Newly Diagnosed Glioblastoma - Mayo Clinic

   Has a diagnosis of immunodeficiency or is receiving chronic systemic steroid therapy (in dosing exceeding 10 mg daily of prednisone equivalent) or any other ...

2. Phenobarbital (intravenous route) - Mayo Clinic

   Leucovorin; Levomethadyl; Methylprednisolone; Metoprolol; Ospemifene; Prednisone; Rufinamide; Theophylline; Tiagabine; Topiramate. Other Interactions. Certain ...

3. Nivolumab in Treating Patients With Relapsed or Refractory Peripheral T-cell Lymphoma - Mayo Clinic

   ... prednisone equivalents are permitted only in adrenal insufficiency in the absence of active autoimmune disease; Prohibited treatments and or therapies.

4. Inflammatory bowel disease (IBD) - Doctors and departments - Mayo Clinic

   Prednisone withdrawal: Why taper down slowly? Ulcerative colitis vs. Crohn's disease. Show more related content. Associated Procedures. Alkaline phosphatase ...

5. Butalbital, aspirin, and caffeine (oral route) - Side effects & dosage - Mayo Clinic

   Prednisone; Propranolol; Sotalol; St John's Wort; Streptokinase; Tamarind; Temocapril; Tenecteplase; Timolol; Warfarin. Other Interactions. Certain medicines ...

6. Mayo Clinic Finds Steroids May Shorten Hospital Stay for Pneumonia Patients

   ROCHESTER, Minn. — Patients with pneumonia may spend fewer days in the hospital if they are given steroids along with antibiotics and supportive care.

7. Fentanyl (transdermal route) - Side effects & dosage - Mayo Clinic

   Fentanyl is a strong opioid analgesic (pain medicine). It acts on the central nervous system (CNS) to relieve pain. When an opioid medicine is used for a long ...

8. A Study to Evaluate the Safety, Pharmacokinetics, and Anti-tumor Activity of LYT-200 Alone and Combined with Chemotherapy or Tislelizumab to Treat Patients with Metastatic Solid Tumors - Mayo Clinic

   ... prednisone or equivalent) for at least 4 weeks prior to the first dose of study drug. Evidence of severe or uncontrolled systemic diseases, congestive heart ...

9. Safety and Tolerability Study of SNS01-T in Relapsed or Refractory B Cell Malignancies (Multiple Myeloma, B Cell Lymphoma, or Plasma Cell Leukemia (PCL) - Mayo Clinic

   Be currently receiving steroids unless equivalent to 20 mg of prednisone or less; Be receiving or have received heparin therapeutically within two days ...

10. A Phase 1 in Patients With HLA-A*0201+ and WT1+ Recurrent/Metastatic Cancers - Mayo Clinic

    Need for concurrent treatment for the CNS disease (e.g., surgery, radiation, corticosteroids > 10 mg prednisone/day or equivalent);; Progression of CNS ...